In SLE, the prevalence of aPL ranges from 12 to 30% for aCL and 15 to 31% for LA, but the prevalence of APS is 10% and this is known to increase with follow – up with an estimated cumulative prevalence of around 30% [1,2,5]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.